{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T09:18:57Z","timestamp":1794734337378,"version":"4.9.1"},"reference-count":131,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","biologicalpsychiatryjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.biopsych.2023.10.008","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T08:15:35Z","timestamp":1697789735000},"page":"992-1005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":174,"title":["Depression in Alzheimer\u2019s Disease: Epidemiology, Mechanisms, and Treatment"],"prefix":"10.1016","volume":"95","author":[{"given":"Yu-Yuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Han","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2532-383X","authenticated-orcid":false,"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2023.10.008_bib1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jad.2023.06.046","article-title":"Bidirectional association between depressive symptoms and mild cognitive impairment over 20 years: Evidence from the Health and Retirement Study in the United States","volume":"338","author":"Guo","year":"2023","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.biopsych.2023.10.008_bib2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/arclin\/acad036","article-title":"Neuropsychological performance in Alzheimer\u2019s disease versus late-life depression: A systematic review and meta-analysis","volume":"38","author":"Barlet","year":"2023","journal-title":"Arch Clin Neuropsychol"},{"key":"10.1016\/j.biopsych.2023.10.008_bib3","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/gps.5556","article-title":"Prevalence of depression, anxiety, and apathy symptoms across dementia stages: A systematic review and meta-analysis","volume":"36","author":"Leung","year":"2021","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-230091","article-title":"Depression in mid- and later-life and risk of dementia in women: A prospective study within the Danish nurses cohort","volume":"93","author":"Hickey","year":"2023","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2023.10.008_bib5","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17r11772","article-title":"Meta-analysis of the prevalence of major depressive disorder among older adults with dementia","volume":"79","author":"Asmer","year":"2018","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109227","article-title":"Associations between depression and cognition, mild cognitive impairment and dementia in persons with diabetes mellitus: A systematic review and meta-analysis","volume":"185","author":"Chow","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.biopsych.2023.10.008_bib7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1192\/bjp.2021.217","article-title":"Association between a history of clinical depression and dementia, and the role of sociodemographic factors: Population-based cohort study","volume":"221","author":"Korhonen","year":"2022","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jad.2020.05.020","article-title":"Risk of Dementia in persons who have previously experienced clinically significant depression, anxiety, or PTSD: A systematic review and meta-analysis","volume":"274","author":"Kuring","year":"2020","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.biopsych.2023.10.008_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003016","article-title":"The association of depression with subsequent dementia diagnosis: A Swedish nationwide cohort study from 1964 to 2016","volume":"17","author":"Holmquist","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.biopsych.2023.10.008_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jad.2022.01.083","article-title":"Depression in adulthood and risk of dementia later in life: A Danish register-based cohort study of 595,828 men","volume":"302","author":"Larsen","year":"2022","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.biopsych.2023.10.008_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00406-022-01389-6","article-title":"Dementia risk in middle-aged patients with schizophrenia, bipolar disorder, and major depressive disorder: A cohort study of 84,824 subjects","volume":"273","author":"Liou","year":"2023","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.biopsych.2023.10.008_bib12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jad.2020.05.059","article-title":"Late-life depression and the risk of dementia in 14 countries: A 10-year follow-up study from the survey of health, ageing and retirement in Europe","volume":"274","author":"Wu","year":"2020","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.biopsych.2023.10.008_bib13","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/alz.12303","article-title":"Association of life-course depression with the risk of dementia in late life: A nationwide twin study","volume":"17","author":"Yang","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopsych.2023.10.008_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41398-021-01269-y","article-title":"Late-life depression and increased risk of dementia: A longitudinal cohort study","volume":"11","author":"Ly","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib15","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/jamapsychiatry.2017.0660","article-title":"Trajectories of depressive symptoms before diagnosis of dementia: A 28-year follow-up study","volume":"74","author":"Singh-Manoux","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib16","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S2215-0366(16)00097-3","article-title":"10-year trajectories of depressive symptoms and risk of dementia: A population-based study","volume":"3","author":"Mirza","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.biopsych.2022.08.026","article-title":"Depression, depression treatments, and risk of incident dementia: A prospective cohort study of 354,313 participants","volume":"93","author":"Yang","year":"2023","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/jgs.14713","article-title":"Depression case finding in individuals with dementia: A systematic review and meta-analysis","volume":"65","author":"Goodarzi","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.biopsych.2023.10.008_bib19","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1007\/s10072-022-06068-x","article-title":"Anxiety and depression in Alzheimer\u2019s disease: A systematic review of pathogenetic mechanisms and relation to cognitive decline","volume":"43","author":"Botto","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.biopsych.2023.10.008_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.638651","article-title":"Depression in Alzheimer\u2019s disease: A Delphi consensus on etiology, risk factors, and clinical management","volume":"12","author":"Ag\u00fcera-Ortiz","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.653130","article-title":"Genetic overlap between Alzheimer\u2019s disease and depression mapped onto the brain","volume":"15","author":"Monereo-S\u00e1nchez","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.biopsych.2023.10.008_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.49","article-title":"Assessing the presence of shared genetic architecture between Alzheimer\u2019s disease and major depressive disorder using genome-wide association data","volume":"7","author":"Gibson","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib23","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3233\/JAD-180276","article-title":"The GWAS risk genes for depression may be actively involved in Alzheimer\u2019s disease","volume":"64","author":"Ni","year":"2018","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2023.10.008_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biopsych.2021.11.025","article-title":"Genetic evidence supporting a causal role of depression in Alzheimer\u2019s disease","volume":"92","author":"Harerimana","year":"2022","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0004867414557161","article-title":"Amyloid-beta and depression in healthy older adults: A systematic review","volume":"49","author":"Harrington","year":"2015","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib26","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.biopsych.2020.07.004","article-title":"Amyloid pathologies modulate the associations of minimal depressive symptoms with cognitive impairments in older adults without dementia","volume":"89","author":"Xu","year":"2021","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jad.2020.03.166","article-title":"Cognitive impairment in remitted late-life depression is not associated with Alzheimer\u2019s disease-related CSF biomarkers","volume":"272","author":"Loureiro","year":"2020","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.biopsych.2023.10.008_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.857940","article-title":"Decreased cerebral amyloid-beta depositions in patients with a lifetime history of major depression with suspected non-Alzheimer pathophysiology","volume":"14","author":"Wu","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.biopsych.2023.10.008_bib29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.biopsych.2020.06.017","article-title":"Late-life depression is associated with reduced cortical amyloid burden: Findings from the Alzheimer\u2019s disease neuroimaging initiative depression project","volume":"89","author":"Mackin","year":"2021","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-160401","article-title":"Tau in late-life depression: A systematic review and meta-analysis","volume":"54","author":"Brown","year":"2016","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2023.10.008_bib31","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/brain\/awaa405","article-title":"Depression, dementia and immune dysregulation","volume":"144","author":"Hayley","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2023.10.008_bib32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1503\/jpn.170192","article-title":"Abnormal protein and mRNA expression of inflammatory cytokines in the prefrontal cortex of depressed individuals who died by suicide","volume":"43","author":"Pandey","year":"2018","journal-title":"J\u00a0Psychiatry Neurosci"},{"key":"10.1016\/j.biopsych.2023.10.008_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0447.2007.01128.x","article-title":"Elevated cytokine expression in the orbitofrontal cortex of victims of suicide","volume":"117","author":"Tonelli","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2023.10.008_bib34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","article-title":"Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue","volume":"81","author":"Enache","year":"2019","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2023.10.008_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pnpbp.2013.08.008","article-title":"Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis","volume":"48","author":"Myint","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib36","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00213-018-5137-8","article-title":"Minocycline prevents the development of depression-like behavior and hippocampal inflammation in a rat model of Alzheimer\u2019s disease","volume":"236","author":"Amani","year":"2019","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.biopsych.2023.10.008_bib37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.phrs.2018.02.007","article-title":"Neurobiological links between depression and AD: The role of TGF-beta1 signaling as a new pharmacological target","volume":"130","author":"Caraci","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.biopsych.2023.10.008_bib38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41398-020-0769-y","article-title":"Shared genetic etiology underlying Alzheimer\u2019s disease and major depressive disorder","volume":"10","author":"Lutz","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib39","series-title":"Alzheimer\u2019s disease genetic burden is associated with mid-life depression among persons with normal cognition [published online Jun 21]","author":"Wingo","year":"2022"},{"key":"10.1016\/j.biopsych.2023.10.008_bib40","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3233\/JAD-191078","article-title":"Depression is associated with tau and not amyloid positron emission tomography in cognitively normal adults","volume":"74","author":"Babulal","year":"2020","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2023.10.008_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.774049","article-title":"Plasma total tau and neurobehavioral symptoms of cognitive decline in cognitively normal older adults","volume":"12","author":"Hall","year":"2021","journal-title":"Front Psychol"},{"key":"10.1016\/j.biopsych.2023.10.008_bib42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/gps.5418","article-title":"Alzheimer\u2019s disease biomarkers as predictors of trajectories of depression and apathy in cognitively normal individuals, mild cognitive impairment, and Alzheimer\u2019s disease dementia","volume":"36","author":"Banning","year":"2021","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biopsych.2022.01.012","article-title":"Development of apathy, anxiety, and depression in cognitively unimpaired older adults: Effects of Alzheimer\u2019s disease pathology and cognitive decline","volume":"92","author":"Johansson","year":"2022","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib44","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neubiorev.2020.02.012","article-title":"Behavioural and psychological symptoms of dementia in mouse models of Alzheimer\u2019s disease-related pathology","volume":"112","author":"Kosel","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2023.10.008_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2013.01.039","article-title":"Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-\u03b2 (\u03b1\u03b2(1\u201340)) administration in mice","volume":"244","author":"dos Santos","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2023.10.008_bib46","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mp.2012.168","article-title":"Amyloid-beta oligomers link depressive-like behavior and cognitive deficits in mice","volume":"18","author":"Ledo","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.899158","article-title":"Depressive symptoms have distinct relationships with neuroimaging biomarkers across the Alzheimer\u2019s clinical continuum","volume":"14","author":"Moulinet","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.biopsych.2023.10.008_bib48","doi-asserted-by":"crossref","first-page":"e1486","DOI":"10.1212\/WNL.0000000000200948","article-title":"Prepandemic Alzheimer disease biomarkers and anxious-depressive symptoms during the COVID-19 confinement in cognitively unimpaired adults","volume":"99","author":"Akinci","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2023.10.008_bib49","first-page":"286","article-title":"Anxiety and depressive symptoms and cortical amyloid-\u03b2 burden in cognitively unimpaired older adults","volume":"9","author":"Lewis","year":"2022","journal-title":"J\u00a0Prev Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2023.10.008_bib50","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1038\/s41467-022-31873-5","article-title":"Shared mechanisms across the major psychiatric and neurodegenerative diseases","volume":"13","author":"Wingo","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2023.10.008_bib51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-publhealth-040218-044106","article-title":"Environmental exposures and depression: Biological mechanisms and epidemiological evidence","volume":"40","author":"van den Bosch","year":"2019","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.biopsych.2023.10.008_bib52","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.53668","article-title":"Association of long-term exposure to air pollution with late-life depression in older adults in the US","volume":"6","author":"Qiu","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.biopsych.2023.10.008_bib53","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12877-016-0342-y","article-title":"Environmental risk factors for dementia: A systematic review","volume":"16","author":"Killin","year":"2016","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.biopsych.2023.10.008_bib54","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41467-021-27604-x","article-title":"Vascular and blood-brain barrier-related changes underlie stress responses and resilience in female mice and depression in human tissue","volume":"13","author":"Dion-Albert","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2023.10.008_bib55","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1038\/s41380-022-01618-3","article-title":"Association between vascular endothelial growth factor-mediated blood-brain barrier dysfunction and stress-induced depression","volume":"27","author":"Matsuno","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib56","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41593-017-0010-3","article-title":"Social stress induces neurovascular pathology promoting depression","volume":"20","author":"Menard","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2023.10.008_bib57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI81108","article-title":"Endothelial LRP1 transports amyloid-\u03b2(1\u201342) across the blood-brain barrier","volume":"126","author":"Storck","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.biopsych.2023.10.008_bib58","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2023.10.008_bib59","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.stem.2021.05.001","article-title":"Restoring miR-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer\u2019s disease","volume":"28","author":"Walgrave","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biopsych.2023.10.008_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198406","article-title":"The reduction of adult neurogenesis in depression impairs the retrieval of new as well as remote episodic memory","volume":"13","author":"Fang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2023.10.008_bib61","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.stem.2023.01.002","article-title":"Adult hippocampal neurogenesis in Alzheimer\u2019s disease: A roadmap to clinical relevance","volume":"30","author":"Salta","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biopsych.2023.10.008_bib62","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41380-018-0036-2","article-title":"The role of adult hippocampal neurogenesis in brain health and disease","volume":"24","author":"Toda","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib63","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.stem.2023.02.006","article-title":"Activation of hypothalamic-enhanced adult-born neurons restores cognitive and affective function in Alzheimer\u2019s disease","volume":"30","author":"Li","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biopsych.2023.10.008_bib64","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.biopsych.2016.12.032","article-title":"Late-life depression, hippocampal volumes, and hypothalamic-pituitary-adrenal axis regulation: A systematic review and meta-analysis","volume":"82","author":"Geerlings","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neurobiolaging.2021.09.025","article-title":"Depressive symptom profiles predict dementia onset and brain pathology in older persons. The AGES-Reykjavik study","volume":"111","author":"Gerritsen","year":"2022","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2023.10.008_bib66","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1176\/appi.ajp.2016.16030319","article-title":"No association of lower hippocampal volume with Alzheimer\u2019s disease pathology in late-life depression","volume":"174","author":"De Winter","year":"2017","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pscychresns.2015.01.018","article-title":"Comparison of regional gray matter volume abnormalities in Alzheimer\u2019s disease and late life depression with hippocampal atrophy using VSRAD analysis: A voxel-based morphometry study","volume":"232","author":"Shimoda","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2023.10.008_bib68","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jad.2020.12.049","article-title":"Cerebral amyloid accumulation is associated with distinct structural and functional alterations in the brain of depressed elders with mild cognitive impairment","volume":"281","author":"Hyung","year":"2021","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.biopsych.2023.10.008_bib69","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fnagi.2018.00310","article-title":"Aberrant default mode network underlying the cognitive deficits in the patients with late-onset depression","volume":"10","author":"Liu","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.biopsych.2023.10.008_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13071111","article-title":"Depression is associated with the aberration of resting state default mode network functional connectivity in patients with amyloid-positive mild cognitive impairment","volume":"13","author":"Wang","year":"2023","journal-title":"Brain Sci"},{"key":"10.1016\/j.biopsych.2023.10.008_bib71","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.neubiorev.2015.07.014","article-title":"Resting-state functional connectivity in major depressive disorder: A review","volume":"56","author":"Mulders","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2023.10.008_bib72","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1017\/S0033291713001980","article-title":"White-matter tract integrity in late-life depression: Associations with severity and cognition","volume":"44","author":"Charlton","year":"2014","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2023.10.008_bib73","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/s41386-021-01072-9","article-title":"Default mode network dissociation linking cerebral beta amyloid retention and depression in cognitively normal older adults","volume":"46","author":"Wang","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2023.10.008_bib74","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00702-014-1347-3","article-title":"Association between altered resting-state cortico-cerebellar functional connectivity networks and mood\/cognition dysfunction in late-onset depression","volume":"122","author":"Yin","year":"2015","journal-title":"J\u00a0Neural Transm (Vienna)"},{"key":"10.1016\/j.biopsych.2023.10.008_bib75","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1017\/S1041610221001174","article-title":"Altered intrinsic default mode network functional connectivity in patients with remitted geriatric depression and amnestic mild cognitive impairment","volume":"34","author":"Guan","year":"2022","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.biopsych.2023.10.008_bib76","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2019.04.002","article-title":"Depression in neurodegenerative diseases: Common mechanisms and current treatment options","volume":"102","author":"Galts","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2023.10.008_bib77","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1017\/S1041610218001199","article-title":"Cortisol levels among older people with and without depression and dementia","volume":"31","author":"Barca","year":"2019","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.biopsych.2023.10.008_bib78","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1176\/appi.ajp.2017.17040404","article-title":"Impact of SSRI therapy on risk of conversion from mild cognitive impairment to Alzheimer\u2019s dementia in individuals with previous depression","volume":"175","author":"Bartels","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib79","doi-asserted-by":"crossref","first-page":"e2658","DOI":"10.1212\/WNL.0000000000010725","article-title":"Effect of escitalopram dose and treatment duration on CSF A\u03b2 levels in healthy older adults: A controlled clinical trial","volume":"95","author":"Sheline","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2023.10.008_bib80","doi-asserted-by":"crossref","first-page":"e2666","DOI":"10.1212\/WNL.0000000000010733","article-title":"Effect of escitalopram on A\u03b2 levels and plaque load in an Alzheimer mouse model","volume":"95","author":"Cirrito","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2023.10.008_bib81","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/jgs.15508","article-title":"Cumulative antidepressant use and risk of dementia in a prospective cohort study","volume":"66","author":"Heath","year":"2018","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.biopsych.2023.10.008_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002728","article-title":"Trazodone use and risk of dementia: A population-based cohort study","volume":"16","author":"Brauer","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.biopsych.2023.10.008_bib83","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jagp.2019.05.019","article-title":"Exposure to antidepressant medication and the risk of incident dementia","volume":"27","author":"Kodesh","year":"2019","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib84","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1177\/0269881120944152","article-title":"Risk of incident dementia in late-life depression treated with antidepressants: A nationwide population cohort study","volume":"34","author":"Su","year":"2020","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2023.10.008_bib85","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jamda.2018.12.004","article-title":"Depression and antidepressants as potential risk factors in dementia: A systematic review and meta-analysis of 18 longitudinal studies","volume":"20","author":"Chan","year":"2019","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.biopsych.2023.10.008_bib86","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13195-022-01026-3","article-title":"Hormone therapy and the decreased risk of dementia in women with depression: A population-based cohort study","volume":"14","author":"Kim","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.biopsych.2023.10.008_bib87","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12877-019-1327-4","article-title":"Systematic review and meta-analysis of second-generation antidepressants for the treatment of older adults with depression: Questionable benefit and considerations for frailty","volume":"19","author":"Mallery","year":"2019","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.biopsych.2023.10.008_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2016.06.013","article-title":"Efficacy and tolerability of antidepressants in people aged 65 years or older with major depressive disorder \u2013 A systematic review and a meta-analysis","volume":"205","author":"Tham","year":"2016","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.biopsych.2023.10.008_bib89","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4088\/JCP.12r07757","article-title":"Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: A meta-analytic review","volume":"74","author":"McHugh","year":"2013","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib90","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cpr.2015.04.002","article-title":"Can non-pharmacological interventions prevent relapse in adults who have recovered from depression? A systematic review and meta-analysis of randomised controlled trials","volume":"39","author":"Clarke","year":"2015","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.biopsych.2023.10.008_bib91","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1017\/S0033291722002537","article-title":"Associations between psychological therapy outcomes for depression and incidence of dementia","volume":"53","author":"John","year":"2023","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2023.10.008_bib92","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3233\/JAD-161247","article-title":"Efficacy of antidepressants for depression in Alzheimer\u2019s disease: Systematic review and meta-analysis","volume":"58","author":"Orgeta","year":"2017","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2023.10.008_bib93","first-page":"CD003944","article-title":"Antidepressants for treating depression in dementia","volume":"8","author":"Dudas","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.biopsych.2023.10.008_bib94","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/02698811211030181","article-title":"Efficacy of antidepressant drugs in the treatment of depression in Alzheimer disease patients: A systematic review and network meta-analysis","volume":"35","author":"He","year":"2021","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2023.10.008_bib95","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fpsyt.2020.00380","article-title":"Depression in the elderly. Consensus statement of the Spanish psychogeriatric association","volume":"11","author":"Ag\u00fcera-Ortiz","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib96","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-023-06891-w","article-title":"Exploring depression in Alzheimer\u2019s disease: An Italian Delphi Consensus on phenomenology, diagnosis, and management","author":"Padovani","year":"2023","journal-title":"Neurol Sci"},{"key":"10.1016\/j.biopsych.2023.10.008_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101362","article-title":"Efficacy of serotonergic antidepressant treatment for the neuropsychiatric symptoms and agitation in dementia: A systematic review and meta-analysis","volume":"69","author":"Hsu","year":"2021","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.biopsych.2023.10.008_bib98","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pharmthera.2014.07.001","article-title":"Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data","volume":"145","author":"Sanchez","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2023.10.008_bib99","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/ijnp\/pyac054","article-title":"Effect of vortioxetine on cognitive impairment in patients with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials","volume":"25","author":"Huang","year":"2022","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2023.10.008_bib100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/ijnp\/pyad018","article-title":"Effectiveness and safety of vortioxetine for the treatment of major depressive disorder in the real world: A systematic review and meta-analysis","volume":"26","author":"Li","year":"2023","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2023.10.008_bib101","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1017\/S104161020100761X","article-title":"A\u00a0double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer\u2019s disease","volume":"13","author":"Petracca","year":"2001","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.biopsych.2023.10.008_bib102","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0033-3182(97)71461-0","article-title":"A\u00a0double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer\u2019s disease","volume":"38","author":"Taragano","year":"1997","journal-title":"Psychosomatics"},{"key":"10.1016\/j.biopsych.2023.10.008_bib103","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3233\/JAD-160225","article-title":"The effect of escitalopram on mood and cognition in depressive Alzheimer\u2019s disease subjects","volume":"55","author":"An","year":"2017","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2023.10.008_bib104","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1099-1166(199802)13:2<100::AID-GPS738>3.0.CO;2-J","article-title":"A\u00a0double-blind comparison of the efficacy and safely of paroxetine and imipramine in the treatment of depression with dementia","volume":"13","author":"Katona","year":"1998","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3233\/JAD-200247","article-title":"The efficacy of sertraline, escitalopram, and nicergoline in the treatment of depression and apathy in Alzheimer\u2019s disease: The Okayama depression and apathy project (ODAP)","volume":"76","author":"Takemoto","year":"2020","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2023.10.008_bib106","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(11)60830-1","article-title":"Sertraline or mirtazapine for depression in dementia (HTA-SADD): A randomised, multicentre, double-blind, placebo-controlled trial","volume":"378","author":"Banerjee","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2023.10.008_bib107","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.60.7.737","article-title":"Treating depression in Alzheimer disease: Efficacy and safety of sertraline therapy, and the benefits of depression reduction: The DIADS","volume":"60","author":"Lyketsos","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib108","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/JGP.0b013e3181cc0333","article-title":"Sertraline for the treatment of depression in Alzheimer disease: Week-24 outcomes","volume":"18","author":"Weintraub","year":"2010","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib109","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-0034-1377041","article-title":"Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients","volume":"47","author":"Mokhber","year":"2014","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib110","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1176\/jnp.8.3.270","article-title":"A\u00a0double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer\u2019s disease","volume":"8","author":"Petracca","year":"1996","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.biopsych.2023.10.008_bib111","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1176\/ajp.146.1.45","article-title":"Double-blind trial of imipramine in Alzheimer\u2019s disease patients with and without depression","volume":"146","author":"Reifler","year":"1989","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib112","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-2007-1014339","article-title":"Video rating analysis of effect of maprotiline in patients with dementia and depression","volume":"26","author":"Fuchs","year":"1993","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib113","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1192\/bjp.168.2.149","article-title":"Moclobemide in elderly patients with cognitive decline and depression: An international double-blind, placebo-controlled trial","volume":"168","author":"Roth","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib114","first-page":"192","article-title":"Treatment effects of vortioxetine on cognitive functions in mild Alzheimer\u2019s disease patients with depressive symptoms: A 12 month, open-label, observational study","volume":"6","author":"Cumbo","year":"2019","journal-title":"J\u00a0Prev Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2023.10.008_bib115","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jpsychires.2022.09.039","article-title":"Global cognitive effects of second-generation antidepressants in patients with Alzheimer\u2019s disease: A systematic review and meta-analysis of randomized controlled trials","volume":"155","author":"Qin","year":"2022","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.biopsych.2023.10.008_bib116","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/070674370705200407","article-title":"Efficacy and safety of antidepressants for treatment of depression in Alzheimer\u2019s disease: A metaanalysis","volume":"52","author":"Thompson","year":"2007","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.biopsych.2023.10.008_bib117","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ijnp\/pyaa048","article-title":"The Phosphodiesterase-4 inhibitor Roflumilast, a potential treatment for the comorbidity of memory loss and depression in Alzheimer\u2019s disease: A preclinical study in APP\/PS1 transgenic mice","volume":"23","author":"Wang","year":"2020","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2023.10.008_bib118","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1523\/JNEUROSCI.5236-10.2011","article-title":"Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling","volume":"31","author":"Li","year":"2011","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2023.10.008_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020513","article-title":"Inhibition of phosphodiesterase 4 by FCPR03 alleviates lipopolysaccharide-induced depressive-like behaviors in mice: Involvement of p38 and JNK signaling pathways","volume":"19","author":"Yu","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.biopsych.2023.10.008_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114045","article-title":"The novel therapeutic strategy of vilazodone-donepezil chimeras as potent triple-target ligands for the potential treatment of Alzheimer\u2019s disease with comorbid depression","volume":"229","author":"Li","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.biopsych.2023.10.008_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114347","article-title":"Discovery of novel dual RAGE\/SERT inhibitors for the potential treatment of the comorbidity of Alzheimer\u2019s disease and depression","volume":"236","author":"Zhang","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.biopsych.2023.10.008_bib122","article-title":"Managing neuropsychiatric symptoms in patients with dementia","volume":"376","author":"Watt","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.biopsych.2023.10.008_bib123","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1017\/S1041610220000216","article-title":"Managing depressive symptoms in people with mild cognitive impairment and mild dementia with a multicomponent psychotherapy intervention: A randomized controlled trial","volume":"33","author":"Tonga","year":"2021","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.biopsych.2023.10.008_bib124","article-title":"Psychological treatments for depression and anxiety in dementia and mild cognitive impairment","volume":"4","author":"Orgeta","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.biopsych.2023.10.008_bib125","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ageing\/afaa063","article-title":"Cognitive training interventions and depression in mild cognitive impairment and dementia: A systematic review and meta-analysis of randomized controlled trials","volume":"49","author":"Chan","year":"2020","journal-title":"Age Ageing"},{"key":"10.1016\/j.biopsych.2023.10.008_bib126","doi-asserted-by":"crossref","first-page":"n532","DOI":"10.1136\/bmj.n532","article-title":"Comparative efficacy of interventions for reducing symptoms of depression in people with dementia: Systematic review and network meta-analysis","volume":"372","author":"Watt","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.biopsych.2023.10.008_bib127","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/ebmental-2019-300113","article-title":"Treatment for depression comorbid with dementia","volume":"22","author":"Baruch","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.biopsych.2023.10.008_bib128","doi-asserted-by":"crossref","first-page":"o518","DOI":"10.1136\/bmj.o518","article-title":"Music as a person centred intervention for dementia","volume":"376","author":"Bolton","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.biopsych.2023.10.008_bib129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1017\/S1041610218000534","article-title":"Management of behavioral and psychological symptoms in people with Alzheimer\u2019s disease: An international Delphi consensus","volume":"31","author":"Kales","year":"2019","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.biopsych.2023.10.008_bib130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13195-014-0074-1","article-title":"Transcranial magnetic stimulation and transcranial direct current stimulation: Treatments for cognitive and neuropsychiatric symptoms in the neurodegenerative dementias?","volume":"6","author":"Elder","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.biopsych.2023.10.008_bib131","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jalz.2019.08.197","article-title":"Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer\u2019s disease","volume":"16","author":"Sabbagh","year":"2020","journal-title":"Alzheimers Dement"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322323016281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322323016281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T16:52:47Z","timestamp":1729097567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322323016281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":131,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0006322323016281"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2023.10.008","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depression in Alzheimer\u2019s Disease: Epidemiology, Mechanisms, and Treatment","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2023.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}